Smith Graham & Co. Investment Advisors LP Has $4.97 Million Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Smith Graham & Co. Investment Advisors LP raised its position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 51.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 534,621 shares of the company's stock after buying an additional 181,662 shares during the period. Smith Graham & Co. Investment Advisors LP owned 0.64% of Pediatrix Medical Group worth $4,972,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC boosted its position in Pediatrix Medical Group by 226.9% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 36,161 shares of the company's stock valued at $336,000 after buying an additional 25,098 shares in the last quarter. Pacer Advisors Inc. boosted its position in Pediatrix Medical Group by 126.9% in the fourth quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company's stock valued at $30,092,000 after buying an additional 1,809,828 shares in the last quarter. Moody National Bank Trust Division boosted its position in Pediatrix Medical Group by 23.4% in the fourth quarter. Moody National Bank Trust Division now owns 41,573 shares of the company's stock valued at $387,000 after buying an additional 7,871 shares in the last quarter. Exchange Traded Concepts LLC lifted its position in shares of Pediatrix Medical Group by 43.7% during the fourth quarter. Exchange Traded Concepts LLC now owns 43,368 shares of the company's stock worth $403,000 after purchasing an additional 13,194 shares in the last quarter. Finally, American Century Companies Inc. lifted its position in shares of Pediatrix Medical Group by 52.6% during the third quarter. American Century Companies Inc. now owns 44,098 shares of the company's stock worth $560,000 after purchasing an additional 15,191 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Trading Down 1.7 %

NYSE MD traded down $0.16 during trading hours on Friday, hitting $9.24. The company's stock had a trading volume of 422,504 shares, compared to its average volume of 732,533. The stock has a fifty day moving average of $9.21 and a 200 day moving average of $9.84. Pediatrix Medical Group, Inc. has a twelve month low of $7.70 and a twelve month high of $15.06. The firm has a market capitalization of $776.44 million, a P/E ratio of -12.66, a PEG ratio of 2.54 and a beta of 1.58. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.73.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, February 20th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.02. Pediatrix Medical Group had a negative net margin of 3.03% and a positive return on equity of 10.35%. The business had revenue of $496.44 million for the quarter, compared to analyst estimates of $524.30 million. During the same period in the prior year, the business posted $0.46 earnings per share. Pediatrix Medical Group's revenue was down 3.4% compared to the same quarter last year. Equities research analysts forecast that Pediatrix Medical Group, Inc. will post 1.12 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on MD. Jefferies Financial Group reduced their target price on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a "hold" rating on the stock in a research report on Wednesday, March 6th. Mizuho reduced their target price on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 21st. TheStreet lowered shares of Pediatrix Medical Group from a "c" rating to a "d" rating in a research report on Friday, February 23rd. Finally, Truist Financial reduced their target price on shares of Pediatrix Medical Group from $10.50 to $10.00 and set a "hold" rating on the stock in a research report on Wednesday, February 21st. Five research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $10.30.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.